Medicare Enrolled
Dr. Michael Baugh, M.D.
Neurology · Gainesville, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Baugh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Baugh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Baugh
Dr. Michael Baugh is a neurology specialist in Gainesville, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Baugh performed 13,687 Medicare services across 908 unique beneficiaries.
Between the years covered by Open Payments, Dr. Baugh received a total of $22,395 from 80 pharmaceutical and/or device companies across 1168 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Baugh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 8% volume in GA
$22,395 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,687
Medicare services
Top 8% in GA for neurology
908
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~720 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
12,500 | $5 | $32 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
428 | $70 | $290 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
121 | $87 | $387 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
105 | $123 | $510 |
| Nerve conduction studies, 13 or more A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed. |
85 | $207 | $838 |
| New patient office visit, complex (60-74 min) | 62 | $157 | $664 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
60 | $149 | $621 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 58 | $54 | $234 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
54 | $55 | $274 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
46 | $314 | $1,334 |
| Chemical nerve block for facial paralysis Injection of a chemical agent to paralyze specific nerves or muscles on the side of the face. |
36 | $126 | $651 |
| Chemical nerve block for neck muscles Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box. |
36 | $140 | $591 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
35 | $108 | $504 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
25 | $134 | $541 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
22 | $42 | $171 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
14 | $177 | $713 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$22,395
Total received (2018-2024)
Avg $3,199/year across 7 years
Top 15% in GA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
80
Companies
1,168
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,143 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$252 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,091
2023
$3,685
2022
$3,513
2021
$3,253
2020
$2,285
2019
$2,991
2018
$2,576
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$420
MDD US Operations, LLC
$403
UCB, Inc.
$379
Neurelis, Inc.
$333
PFIZER INC.
$305
ARGENX US, INC.
$213
Novartis Pharmaceuticals Corporation
$192
Neurocrine Biosciences, Inc.
$189
Lundbeck LLC
$179
Biogen, Inc.
$170
CATALYST PHARMACEUTICALS, INC.
$150
Teva Pharmaceuticals USA, Inc.
$149
Celgene Corporation
$127
Lilly USA, LLC
$119
Kyowa Kirin, Inc.
$102
Eisai Inc.
$96
Sumitomo Pharma America, Inc.
$75
ACADIA Pharmaceuticals Inc
$67
Alexion Pharmaceuticals, Inc.
$59
Vanda Pharmaceuticals Inc.
$56
Amgen Inc.
$45
Amneal Pharmaceuticals LLC
$44
Genentech USA, Inc.
$37
SK Life Science, Inc.
$35
BANNER LIFE SCIENCES, LLC
$32
Amylyx Pharmaceuticals, Inc.
$30
Takeda Pharmaceuticals U.S.A., Inc.
$24
MITSUBISHI TANABE PHARMA AMERICA, INC.
$23
Kedrion Biopharma, Inc.
$22
Grifols USA, LLC
$15
Top 3 companies account for 29.4% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$1,637
Biogen, Inc.
$1,197
AbbVie Inc.
$1,085
Amgen Inc.
$982
Neurelis, Inc.
$841
Novartis Pharmaceuticals Corporation
$774
Teva Pharmaceuticals USA, Inc.
$769
ABBVIE INC.
$763
PFIZER INC.
$635
ACADIA Pharmaceuticals Inc
$631
Neurocrine Biosciences, Inc.
$626
MDD US Operations, LLC
$624
GENZYME CORPORATION
$609
SK Life Science, Inc.
$494
Kyowa Kirin, Inc.
$481
Supernus Pharmaceuticals, Inc.
$474
ARGENX US, INC.
$466
Allergan, Inc.
$463
Lundbeck LLC
$458
Alexion Pharmaceuticals, Inc.
$454
Upsher-Smith Laboratories LLC
$424
Lilly USA, LLC
$420
Adamas Pharmaceuticals, Inc.
$404
Sunovion Pharmaceuticals Inc.
$399
Eisai Inc.
$386
CSL Behring
$370
Amneal Pharmaceuticals LLC
$365
Ipsen Biopharmaceuticals, Inc
$362
Allergan Inc.
$357
Genentech USA, Inc.
$353
EISAI INC.
$319
EMD Serono, Inc.
$313
Sumitomo Pharma America, Inc.
$275
US WorldMeds, LLC
$212
Avanir Pharmaceuticals, Inc.
$201
Acorda Therapeutics, Inc
$174
Celgene Corporation
$174
Biohaven Pharmaceutical Holding Company Ltd.
$169
CATALYST PHARMACEUTICALS, INC.
$169
IMPEL PHARMACEUTICALS INC.
$157
AstraZeneca Pharmaceuticals LP
$116
UPSHER-SMITH LABORATORIES LLC
$114
Grifols USA, LLC
$113
AbbVie, Inc.
$106
Janssen Pharmaceuticals, Inc
$102
BANNER LIFE SCIENCES, LLC
$100
Amylyx Pharmaceuticals, Inc.
$96
Catalyst Pharmaceuticals, Inc.
$82
Avion Pharmaceuticals
$80
Mallinckrodt Hospital Products Inc.
$72
LivaNova USA, Inc.
$71
MITSUBISHI TANABE PHARMA AMERICA, INC.
$68
Banner Life Sciences, LLC
$56
Vanda Pharmaceuticals Inc.
$56
Biohaven Pharmaceuticals, Inc.
$50
Merz Pharmaceuticals, LLC
$46
Mitsubishi Tanabe Pharma America, Inc.
$46
Aprecia Pharmaceuticals, LLC
$44
Impax Laboratories, Inc.
$43
SANOFI-AVENTIS U.S. LLC
$41
Abbott Laboratories
$36
Boston Scientific Corporation
$35
GE HEALTHCARE
$31
Terumo BCT, Inc.
$26
Cala Health, Inc.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$24
Horizon Therapeutics plc
$23
Kedrion Biopharma, Inc.
$22
Corium, LLC
$22
Medtronic USA, Inc.
$20
JAZZ PHARMACEUTICALS INC.
$20
E.R. Squibb & Sons, L.L.C.
$19
Nevro Corp.
$18
Merz North America, Inc.
$18
BOSTON SCIENTIFIC CORPORATION
$17
Currax Pharmaceuticals LLC
$16
Zyla Life Sciences
$15
Neuronetics, Inc.
$15
ASSERTIO THERAPEUTICS, Inc.
$15
Zyla Life Sciences, Inc.
$12
Top 3 companies account for 17.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aduhelm · Aimovig · Albuked · Apokyn · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Briviact · CALA TRIO · COPAXONE · CREXONT · DUOPA · DYSPORT · Dhivy · Duopa · Dysport · EMGALITY · EPIDIOLEX · FIRDAPSE · FYCOMPA · Fycompa · GENERAL PAIN MANAGEMENT · GILENYA · GOCOVRI · Gamunex-C · Gocovri · Gralise · HYQVIA · Hizentra · INBRIJA · INGREZZA · Infinity DBS Pulse Generators · KESIMPTA · KYNMOBI · LEMTRADA · LUMIZYME · Leqembi · MAYZENT · MYOBLOC · Mavenclad · NEUROSTAR TMS THERAPY SYSTEM · NEXVIAZYME · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONZETRA XSAIL · ONZETRA Xsail · OXTELLAR XR · Ocrevus · Omnia · Ongentys · PANZYGA · POMPE - DISEASE · PONVORY · Ponvory · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · RELYVRIO · REXULTI · RYTARY · Radicava · Rebif · Rystiggo · SEEBRI · SOLIRIS · SPECTRA WAVEWRITER · SPRIX · Soliris · Spectra Optia Apheresis System · Spritam · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VECTRIS · VNS - Sentiva · VNS Therapy · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAVEWRITER ALPHA · XEOMIN · Xadago · Xeomin · ZAVZPRET · ZEPOSIA · Zembrace SymTouch Sumatriptan Injection · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
44
Per 100K population
21.1
County median income
$77,430
Nearest hospital
NORTHEAST GEORGIA MEDICAL CENTER, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Baugh is a mixed practice specialist, with above-average Medicare volume (top 8% in GA), with low-engagement industry engagement in the top 15% of GA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Baugh experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Baugh performed 12,500 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Baugh receive payments from pharmaceutical companies?
Yes. Dr. Baugh received a total of $22,395 from 80 companies across 1,168 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Baugh's costs compare to other neurologists in Gainesville?
Dr. Baugh's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Baugh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Gainesville
Browse neurologists in Gainesville ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in GA
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in GA
Which GA neurologists receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology